Abstract
The possibility of using Prostaglandins for termination of early pregnancy was evaluated in 1971 (Karim, 1971). One of the objectives has been to develop a non-surgical, out-patient, possibly self-administered method as an alternative to vacuum aspiration in very early pregnancy (up to 49 days of amenorrhea).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bygdeman, M. (1979). Menstrual regulation with Prostaglandins. In Karim, S. M. M. (ed.). Practical Applications of Prostaglandins and their Synthesis Inhibitors. pp. 267–282. ( Lancaster: MTP Press )
Bygdeman, M., Bremme, K., Christensen, N., Lundström, V. and Gréen, K. (1980). A comparison of two stable Prostaglandin E analogues for termination of early pregnancy and for cervical dilatation. Contraception, 22, 471–483
Bygdeman, M., Christensen, N., Gréen, K. and Zheng, S. (1981). Self-administration of Prostaglandin for termination of early pregnancy. Contraception, 24, 45–52
Bygdeman, M., Christensen, N. J., Gréen, K., Zheng, S. and Lundström, V. (1983). Termination of early pregnancy. Future development. Acta Obstet. Gynecol. Scand., Suppl. 113, 125–129
Bygdeman, M., Gréen, K., Bergström, S., Bundy, G. and Kimball, F. (1979). New Prostaglandin E2 analogue for pregnancy termination. Lancet, 1, 1136
Gréen, K., Vesterqvist, O., Bygdeman, M., Christensen, N. J. and Bergström, S. (1982). Plasma levels of 9-deoxo-16,16-dimethyl-9-methylene PGE2 in connection with its development as an abortifacient. Prostaglandins, 24, 451–466
Karim, S. M. M. (1971). Once-a-month vaginal administration of Prostaglandins E2 and F2α for fertility control. Contraception, 3, 173–183
Karim, S. M. M., Rao, B., Ratnam, S. S., Prasad, R. N. V., Wong, Y. M. and Ilancheran, A. (1977). Termination of early pregnancy (menstrual induction) with 16-phenoxy-ω-tetrano PGE2 methyl sulfonylamide. Contraception, 16, 377–381
Kimball, F. A., Bundy, G. L., Robert, A. and Weeks, J. R. (1979). Synthesis and biological properties of 9-deoxo-16,16-dimethyl-9-methylene PGE2. Prostaglandins, 17, 657–666
Mocsary, P. and Csapo, A. I. (1975). Work in progress. Menstrual induction with PGF2α and PGE2. Prostaglandins, 10, 545–547
Takagi, S., Sakata, H., Yoshida, T., Den, K., Fujii, K., Amemiya, H. and Tomita, M. (1978). Termination of early pregnancy by ONO-802 suppositories (16,16-dimethyl-trans-Δp2-PGE1 methyl ester). Prostaglandins, 15, 913–919
Tredway, D. R. and Mishell, D. R. (1973). Therapeutic abortion of early human gestation with vaginal suppositories of Prostaglandin F2α. Am. J. Obstet. Gynecol., 116, 795–798
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Bygdeman, M., Christensen, N.J., Gréen, K., Vesterqvist, O. (1984). Self-administration at home of prostaglandin for termination of early pregnancy. In: Toppozada, M.K., Bygdeman, M., Hafez, E.S.E. (eds) Prostaglandins and Fertility Regulation. Advances in Reproductive Health Care, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5600-1_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-5600-1_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8969-2
Online ISBN: 978-94-009-5600-1
eBook Packages: Springer Book Archive